$GTHX G1 Therapeutics, Inc. Insider Trading Week 41/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. in week 41/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 0.39 | 6,300 | 2,457 | 97,444 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 3,776 | 15,746 | 73,071 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 0.39 | 6,300 | 2,457 | 14,700 | 8.4 K to 14.7 K (+75.00 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 42.01 | 2,833 | 119,019 | 8,400 | 11.2 K to 8.4 K (-25.22 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 40.80 | 943 | 38,478 | 11,233 | 12.2 K to 11.2 K (-7.74 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 3,776 | 15,746 | 12,176 | 8.4 K to 12.2 K (+44.95 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 124,433 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,900 | 389,286 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 42.01 | 2,837 | 119,177 | 19,000 | 21.8 K to 19 K (-12.99 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 40.90 | 2,163 | 88,469 | 21,837 | 24 K to 21.8 K (-9.01 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 24,000 | 19 K to 24 K (+26.32 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 10,000 | 3,900 | 19,000 | 9 K to 19 K (+111.11 %) |